INSM
Time to buy INSM?Insmed Incorporated
$108.84
+$2.44 (2.29%)Prices delayed. Get real-time quotes here!
2 Days. Real Options Skills.
Join options trader Ben Sturgill as he reveals his most reliable options strategies - live. Seats are limited.
Save your seatTrader's Perspective
INSM faded from roughly $145 in early May to about $109 after its May 7 earnings reaction, even as BRINSUPRI revenue kept growing and 2026 guidance stayed intact.
RANGE
CURRENT: $109.21
Support: $105 Target: $135
Support: $105Current: $109.21 Target: $135
BEARISH SCENARIO
If the stock loses $105, it has the potential to slide toward the $95 to $100 zone. Any softer BRINSUPRI launch updates, or another guide-through quarter that fails to impress, would add pressure fast.
BULLISH SCENARIO
If INSM holds the $105 to $110 area and buyers step back in on solid volume, a rebound toward $125 to $135 is on the table. Resistance near $115 is the first hurdle, then the mid-$120s matter.
CATALYSTS:
Analysis generated: May 28, 2026 at 1:17 PM ET
Analyst Ratings
N/A
Average Price Target: $0
Based on 0 analyst ratings in the last 3 months
Sell
0
Hold
0
Buy
0
Insmed Incorporated Earnings
We don't currently have information about Insmed Incorporated's earnings.